Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad A Altamimi

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
AAPS Pharmscitech|March 25, 2021
Experimental Solubility, Thermodynamic/Computational Validations, and GastroPlus-Based In Silico Prediction for Subcutaneous Delivery of RifampicinWael A Mahdi, Afzal Hussain, Mohammad A Altamimi, et al.
AAPS Pharmscitech|July 11, 2024
HSPiP, Computational, and Thermodynamic Model-Based Optimized Solvents for Subcutaneous Delivery of Tolterodine Tartrate and GastroPlus‑Based In Vivo Prediction in Humans: Part IITasneem Khan, Afzal Hussain, Mohd Usman Mohd Siddique, et al.
AAPS Pharmscitech|June 29, 2021
Experimental Solubility of Ketoconazole, Validation Models, and In vivo Prediction in Human Based on GastroPlusAfzal Hussain, Mohammad A Altamimi, Sultan Alshehri, et al.
ACS Omega|January 15, 2024
HSPiP, Computational Modeling, and QbD-Assisted Optimized Method Validation of 5-Fluorouracil for Transdermal ProductsAfzal Hussain, Mohhammad Ramzan, Mohammad A Altamimi, et al.
Nanomedicine (London, England)|February 3, 2022
A voyage from 3D to 4D printing in nanomedicine and healthcare: part IIGourvi Kumari, Kumar Abhishek, Sneha Singh, et al.
Nanomedicine (London, England)|February 3, 2022
A voyage from 3D to 4D printing in nanomedicine and healthcare: part IGourvi Kumari, Kumar Abhishek, Sneha Singh, et al.
International Journal of Pharmaceutics|January 16, 2023
Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspectiveSumel Ashique, Obaid Afzal, Sabina Yasmin, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|July 13, 2019
Evaluation of the bioavailability of hydrocortisone when prepared as solid dispersionMohammad A Altamimi, Ehab M Elzayat, Wajhul Qamar, et al.
ACS Omega|January 17, 2022
Formulation and Evaluation of Luteolin-Loaded Nanovesicles: <i>In Vitro</i> Physicochemical Characterization and Viability AssessmentSyed Sarim Imam, Sultan Alshehri, Mohammad A Altamimi, et al.
Drug Delivery|November 19, 2020
Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patentsSultan Alshehri, Syed Sarim Imam, Afzal Hussain, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
AAPS Pharmscitech|March 25, 2021
Experimental Solubility, Thermodynamic/Computational Validations, and GastroPlus-Based In Silico Prediction for Subcutaneous Delivery of RifampicinWael A Mahdi, Afzal Hussain, Mohammad A Altamimi, et al.
AAPS Pharmscitech|July 11, 2024
HSPiP, Computational, and Thermodynamic Model-Based Optimized Solvents for Subcutaneous Delivery of Tolterodine Tartrate and GastroPlus‑Based In Vivo Prediction in Humans: Part IITasneem Khan, Afzal Hussain, Mohd Usman Mohd Siddique, et al.
AAPS Pharmscitech|June 29, 2021
Experimental Solubility of Ketoconazole, Validation Models, and In vivo Prediction in Human Based on GastroPlusAfzal Hussain, Mohammad A Altamimi, Sultan Alshehri, et al.
ACS Omega|January 15, 2024
HSPiP, Computational Modeling, and QbD-Assisted Optimized Method Validation of 5-Fluorouracil for Transdermal ProductsAfzal Hussain, Mohhammad Ramzan, Mohammad A Altamimi, et al.
Nanomedicine (London, England)|February 3, 2022
A voyage from 3D to 4D printing in nanomedicine and healthcare: part IIGourvi Kumari, Kumar Abhishek, Sneha Singh, et al.
Nanomedicine (London, England)|February 3, 2022
A voyage from 3D to 4D printing in nanomedicine and healthcare: part IGourvi Kumari, Kumar Abhishek, Sneha Singh, et al.
International Journal of Pharmaceutics|January 16, 2023
Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspectiveSumel Ashique, Obaid Afzal, Sabina Yasmin, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|July 13, 2019
Evaluation of the bioavailability of hydrocortisone when prepared as solid dispersionMohammad A Altamimi, Ehab M Elzayat, Wajhul Qamar, et al.
ACS Omega|January 17, 2022
Formulation and Evaluation of Luteolin-Loaded Nanovesicles: <i>In Vitro</i> Physicochemical Characterization and Viability AssessmentSyed Sarim Imam, Sultan Alshehri, Mohammad A Altamimi, et al.
Drug Delivery|November 19, 2020
Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patentsSultan Alshehri, Syed Sarim Imam, Afzal Hussain, et al.
Pageof 8